# reload+after+2024-01-20 11:47:07.630410
address1§Jerusalem BioPark Building
address2§2nd floor Hadassah Ein Kerem Campus
city§Jerusalem
country§Israel
phone§972 8 930 2529
fax§972 8 930 2531
website§https://www.scinai.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
fullTimeEmployees§33
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Amir  Reichman M.B.A., M.Sc.', 'age': 47, 'title': 'CEO & Director', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 562497, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Elad  Mark B.Sc., Eng., M.B.A.', 'age': 41, 'title': 'Chief Operating Officer', 'yearBorn': 1982, 'fiscalYear': 2022, 'totalPay': 277016, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tamar  Ben-Yedidia Ph.D.', 'age': 59, 'title': 'Chief Science Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 314924, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Uri  Ben-Or C.P.A., CPA, M.B.A., MBA', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 582000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joshua E. Phillipson B.Sc., M.B.A.', 'title': 'Director of Communications & Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Moran Ahdout Fruchter L.L.B.', 'title': 'Chief of Staff', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Dalit Weinstein Fischer', 'title': 'VP and Head of Technical R&D', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Merav  Kamensky', 'title': 'Head of Quality Control', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Maxim  Leykin', 'title': 'Head of Engineering', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.484
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§Scinai Immunotherapeutics Ltd.
longName§Scinai Immunotherapeutics Ltd.
firstTradeDateEpochUtc§1431351000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§3111570f-b99f-34c6-94ec-6afda707f452
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§4.137
earningsGrowth§0.259
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
